| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T124 |
0-140 |
Sentence |
denotes |
The LDL, HDL and TC levels in the patients that did not survive (n = 4) decreased continuously until death (Fig. 1, Supplementary Table S1). |
| T125 |
141-330 |
Sentence |
denotes |
Particularly, LDL levels showed an irreversible decrease by the most percentage (~60%) until death (1.1 (0.9–1.2), p = 0.02 versus the levels on admission) (Fig. 1, Supplementary Table S1). |
| T126 |
331-523 |
Sentence |
denotes |
Supplementary table S2 showed a timeline of disease course for a non-surviving patient, from hospital admission to death, with continuous and irreversible decreases in LDL, HDL, and TC levels. |
| T127 |
524-754 |
Sentence |
denotes |
LDL, HDL and TC levels in normal subjects and non-COVID-19 patients (COPD) control groups did not show significant difference as compared with the levels in COVID-19 patients before their viral infections (Supplementary Table S3). |
| T128 |
755-907 |
Sentence |
denotes |
Logistic regression analysis showed increasing odds of lowered LDL levels associated with disease progression (Chi-Square = 7.49; p = 0.006; odds ratio: |
| T129 |
908-921 |
Sentence |
denotes |
4.48, 95% IC: |
| T130 |
922-1014 |
Sentence |
denotes |
1.55–12.92, p = 0.006) and in-hospital mortality (Chi-Square = 10.87; p = 0.001; odds ratio: |
| T131 |
1015-1029 |
Sentence |
denotes |
21.72, 95% IC: |
| T132 |
1030-1054 |
Sentence |
denotes |
1.40–337.54, p = 0.028). |
| T133 |
1055-1180 |
Sentence |
denotes |
The ratio changes of LDL, HDL and TC inversely correlated with the ratio changes of hsCRP during the disease course (Fig. 1). |
